Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Active or passive immunization in unexplained recurrent miscarriage.

Ole B Christiansen1, Henriette S Nielsen, Bjorn Pedersen

  • 1Fertility Clinic 4071, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. obc@pregnancyloss.dk

Journal of Reproductive Immunology
|August 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing and validating a machine learning approach for prediction of euploid pregnancy loss in the Copenhagen pregnancy loss study.

Fertility and sterility·2026
Same author

Sequence Diversity Lost in Early Pregnancy.

Obstetrical & gynecological survey·2026
Same author

An assessment of methods for measuring body composition in full-term infants: A systematic review.

Pediatric research·2025
Same author

Genome-wide analyses identify 25 infertility loci and relationships with reproductive traits across the allele frequency spectrum.

Nature genetics·2025
Same author

Longitudinal study of family formation in 892 women and 193 men 8 years after visiting the Fertility Assessment and Counselling (FAC) clinic.

Acta obstetricia et gynecologica Scandinavica·2025
Same author

Genome-wide analyses identify 21 infertility loci and over 400 reproductive hormone loci across the allele frequency spectrum.

medRxiv : the preprint server for health sciences·2024

Active immunotherapy with allogeneic lymphocyte transfusions (ALT) and passive immunotherapy with intravenous immunoglobulin (IvIg) may improve live birth rates in specific subgroups of women with recurrent miscarriages (RM). Further research is needed to confirm efficacy in tailored patient populations.

Area of Science:

  • Reproductive Immunology
  • Immunotherapy
  • Obstetrics

Background:

  • Unexplained recurrent miscarriage (RM) presents a significant challenge in reproductive medicine.
  • The efficacy of immunotherapies like allogeneic lymphocyte transfusions (ALT) and intravenous immunoglobulin (IvIg) for RM remains debated.
  • Previous meta-analyses have yielded inconclusive results for the general RM population due to trial heterogeneity.

Purpose of the Study:

  • To evaluate the effectiveness of specific immunotherapy protocols in subgroups of women with recurrent miscarriages.
  • To investigate the potential benefits of ALT and IvIg in primary versus secondary RM.
  • To highlight the need for further placebo-controlled trials focusing on patient stratification.

Main Methods:

  • Analysis of placebo-controlled trials conducted in Danish RM clinics since 1986.

Related Experiment Videos

  • Administration of higher doses of ALT and IvIg compared to other studies.
  • Focus on specific patient subsets within the recurrent miscarriage population.

    • Main Results:

    • Evidence suggests ALT may be effective in primary RM and IvIg in secondary RM.
    • Larger doses and specific protocols may enhance treatment efficacy.
    • Current routine therapy in Danish RM clinics is based on these findings.

    Conclusions:

    • Immunotherapy with ALT and IvIg can be effective when applied to the correct patient subsets with appropriate protocols.
    • New placebo-controlled trials are urgently required to validate efficacy in stratified RM populations.
    • Monitoring immune parameters in treated patients is crucial for understanding mechanisms and predicting pregnancy success.